Morphine

Verify with FDA CVM →

349 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
349
Total Reports
72
Deaths Reported
2060.0%
Death Rate

Active Ingredients

Morphine

Administration Routes

UnknownIntramuscularSubcutaneousIntravenousParenteralEpiduralOral

Species Affected

Dog 276
Cat 57
Horse 6
Human 3
Pig 2
Goat 2
Donkey 1
Other 1
Cattle 1

Most Affected Breeds

Retriever - Labrador 50
Domestic Shorthair 35
Dog (unknown) 25
Boxer (German Boxer) 14
Crossbred Canine/dog 14
Retriever - Golden 11
Dachshund (unspecified) 10
Chihuahua 9
Terrier - Yorkshire 8
Shih Tzu 8

Most Reported Reactions

Vomiting 54
Other abnormal test result NOS 48
Lethargy (see also Central nervous system depression in 'Neurological') 42
Death 38
Anorexia 37
Death by euthanasia 34
Lack of efficacy - NOS 32
Bradycardia 24
Elevated alanine aminotransferase (ALT) 20
Weight loss 20
Seizure NOS 20
Not eating 20

Outcome Breakdown

Recovered/Normal
141 (40.8%)
Ongoing
70 (20.2%)
Outcome Unknown
57 (16.5%)
Died
37 (10.7%)
Euthanized
36 (10.4%)
Recovered with Sequela
5 (1.4%)

Data Summary

Metric Value
Total adverse event reports 349
Reports involving death 72
Case-fatality rate (reported events) 2060.0%
Distinct species in reports 9
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Morphine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 349 adverse event reports referencing Morphine, including 72 reports in which the animal died — a 2060.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Morphine. Reported administration routes include Unknown, Intramuscular, Subcutaneous, Intravenous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Morphine reports are Dog (276 reports), Cat (57 reports), Horse (6 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (50), Domestic Shorthair (35), Dog (unknown) (25) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Morphine are Vomiting (54), Other abnormal test result NOS (48), Lethargy (see also Central nervous system depression in 'Neurological') (42), Death (38). Of the 346 reports with a coded outcome, Recovered/Normal is the leading category at 40.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Morphine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial